These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 35072577
1. Prognostic Significance of Platelet (PLT) and Platelet to Mean Platelet Volume (PLT/MPV) Ratio During Apatinib Second-Line or Late-Line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients. Su R, Zhu J, Wu S, Luo H, He Y. Technol Cancer Res Treat; 2022; 21():15330338211072974. PubMed ID: 35072577 [Abstract] [Full Text] [Related]
2. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Zhang F, Chen Z, Wang P, Hu X, Gao Y, He J. Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631 [Abstract] [Full Text] [Related]
3. Association of mean platelet volume (MPV), MPV/PLATELET (PLT) ratio, and lymphocyte/monocyte ratio (LMR) as poor prognostic factor in EGFR-mutant lung adenocarcinoma treated with EGFR tyrosine kinase inhibitor. Kurt HG, Akinci Özyürek B, Erdoğan Y, Akyürek N. Tuberk Toraks; 2024 Sep; 72(3):197-207. PubMed ID: 39275932 [Abstract] [Full Text] [Related]
4. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma. Zhao J, Lei J, Yu J, Zhang C, Song X, Zhang N, Wang Y, Zhang S. Invest New Drugs; 2020 Apr; 38(2):500-506. PubMed ID: 31650447 [Abstract] [Full Text] [Related]
5. The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma. Sun SY, Zhao BQ, Wang J, Mo ZX, Zhao YN, Wang Y, He J. Dis Esophagus; 2018 Feb 01; 31(2):. PubMed ID: 29077856 [Abstract] [Full Text] [Related]
6. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer. Gao L, Zhang H, Zhang B, Zhang L, Wang C. Oncotarget; 2017 Feb 28; 8(9):15632-15641. PubMed ID: 28152504 [Abstract] [Full Text] [Related]
7. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma. Fu M, Li Z, Ma J, Shen F, Zhang X. Scand J Gastroenterol; 2024 Jun 28; 59(6):722-729. PubMed ID: 38362884 [Abstract] [Full Text] [Related]
9. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy. Wang Y, Lyu J, Jia H, Liang L, Xiao L, Liu Y, Liu X, Li K, Chen T, Zhang R, Zhang H, Tang C, Li T. Future Oncol; 2021 Jul 28; 17(20):2647-2657. PubMed ID: 34008415 [Abstract] [Full Text] [Related]
10. The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma. Hu L, Kong Z, Meng Q, Wang J, Zhou M, Yu J, Jiang X. Med Sci Monit; 2020 Nov 27; 26():e927221. PubMed ID: 33243967 [Abstract] [Full Text] [Related]
13. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Han L, Li YJ, Zhang WD, Song PP, Li H, Li S. Medicine (Baltimore); 2019 Feb 27; 98(6):e13921. PubMed ID: 30732126 [Abstract] [Full Text] [Related]
15. Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma. Park JW, Kim CH, Ha YC, Kim MY, Park SM. J Korean Assoc Oral Maxillofac Surg; 2017 Oct 27; 43(5):305-311. PubMed ID: 29142864 [Abstract] [Full Text] [Related]
16. Mean platelet volume and mean platelet volume/platelet count ratio in nonvalvular atrial fibrillation stroke and large artery atherosclerosis stroke. Zhu N, Shu H, Jiang W, Wang Y, Zhang S. Medicine (Baltimore); 2020 Jul 10; 99(28):e21044. PubMed ID: 32664115 [Abstract] [Full Text] [Related]
17. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer. Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, Menekse S, Kocar M, Sen CA, Ordu C, Goksel G, Meydan N, Barutca S, Turkish Descriptive Oncological Researches Group. Clin Respir J; 2018 Mar 10; 12(3):922-929. PubMed ID: 28026133 [Abstract] [Full Text] [Related]